WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005113758) PROCESS FOR THE PRODUCTION OF AN INFLUENZA VACCINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/113758    International Application No.:    PCT/US2005/017606
Publication Date: 01.12.2005 International Filing Date: 20.05.2005
IPC:
C12N 5/07 (2010.01), A61K 39/12 (2006.01), A61K 39/145 (2006.01), C12N 5/00 (2006.01), C12N 7/00 (2006.01), C12N 7/02 (2006.01)
Applicants: ID BIOMEDICAL CORPORATION [CA/CA]; 525 Cartier Boulevard West, Laval, Quebec H7V 3S8 (CA) (For All Designated States Except US).
ID BIOMEDICAL CORPORATION OF WASHINGTON [US/US]; 19204 North Creek Parkway, Suite 100, Bothell, WA 98011 (US) (LS only).
TREPANIER, Pierre [CA/CA]; (CA) (For US Only).
DUGRE, Robert [CA/CA]; (CA) (For US Only).
HASSELL, Tom [GB/CA]; (CA) (For US Only)
Inventors: TREPANIER, Pierre; (CA).
DUGRE, Robert; (CA).
HASSELL, Tom; (CA)
Agent: ROSOK, Mae, Joanne; Seed Intellectual Property Law Group PLLC, Suite 6300, 701 Fifth Avenue, Seattle, WA 98104-7092 (US)
Priority Data:
60/572,612 20.05.2004 US
Title (EN) PROCESS FOR THE PRODUCTION OF AN INFLUENZA VACCINE
(FR) PROCÉDÉ POUR LA FABRICATION D’UN VACCIN CONTRE LA GRIPPE
Abstract: front page image
(EN)The present invention relates to a commercial-scale process for the production of influenza virus or antigens for prophylactic, diagnostic, immunotherapeutic or therapeutic purposes. Particularly, the invention provides a Madin-Darby Canine Kidney (MDCK)-derived, cell line and a cell culture-based process for the production of an influenza vaccine and more particularly, a human vaccine comprising influenza types A and B.
(FR)La présente invention concerne un procédé à l’échelle commerciale pour la production de virus de la grippe ou d’antigènes à des fins de prophylaxie, de diagnostic, d’immunothérapie ou de thérapie. Particulièrement, l’invention fournit un procédé basé sur la lignée cellulaire et la culture cellulaire dérivées de cellules canines de rein Madin-Darby (MDCK) pour la production d’un vaccin contre la grippe et plus particulièrement, d’un vaccin humain englobant les grippes de types A et B.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)